Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Reactive Oxygen and Nitrogen Species-Induced Protein Modifications: Implication in Carcinogenesis and Anticancer Therapy.

Moldogazieva NT, Lutsenko SV, Terentiev AA.

Cancer Res. 2018 Nov 1;78(21):6040-6047. doi: 10.1158/0008-5472.CAN-18-0980. Epub 2018 Oct 16. Review.

PMID:
30327380
2.

ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications.

Moldogazieva NT, Mokhosoev IM, Feldman NB, Lutsenko SV.

Free Radic Res. 2018 May;52(5):507-543. doi: 10.1080/10715762.2018.1457217. Epub 2018 Apr 19. Review.

PMID:
29589770
3.

Endostatin: current concepts about its biological role and mechanisms of action.

Digtyar AV, Pozdnyakova NV, Feldman NB, Lutsenko SV, Severin SE.

Biochemistry (Mosc). 2007 Mar;72(3):235-46. Review.

PMID:
17447877
4.

Tumor angiogenesis inhibitors.

Kiselev SM, Lutsenko SV, Severin SE, Severin ES.

Biochemistry (Mosc). 2003 May;68(5):497-513. Review.

PMID:
12882631
5.

Molecular mechanisms of tumor angiogenesis.

Lutsenko SV, Kiselev SM, Severin SE.

Biochemistry (Mosc). 2003 Mar;68(3):286-300. Review.

PMID:
12733970
6.
7.
8.

Antitumor activity of alpha fetoprotein and epidermal growth factor conjugates in vitro and in vivo.

Lutsenko SV, Feldman NB, Finakova GV, Gukasova NV, Petukhov SP, Posypanova GA, Skryabin KG, Severin SE.

Tumour Biol. 2000 Nov-Dec;21(6):367-74.

PMID:
11006577
9.

Antitumor activity of alpha-fetoprotein conjugate with doxorubicin in vitro and in vivo.

Feldman NB, Kiselev SM, Gukasova NV, Posypanova GA, Lutsenko SV, Severin SE.

Biochemistry (Mosc). 2000 Aug;65(8):967-71.

PMID:
11002192
10.

Cytotoxic action of conjugates of alpha-fetoprotein and epidermal growth factor with photoheme, chlorines, and phthalocyanines.

Savitsky AA, Gukasova NV, Gumanov SG, Feldman NB, Luk'yanets EA, Mironov AF, Yakubovskaya RI, Lutsenko SV, Severin SE.

Biochemistry (Mosc). 2000 Jun;65(6):732-6.

PMID:
10887296
11.

Targeting phthalocyanines to tumor cells using epidermal growth factor conjugates.

Lutsenko SV, Feldman NB, Finakova GV, Posypanova GA, Severin SE, Skryabin KG, Kirpichnikov MP, Lukyanets EA, Vorozhtsov GN.

Tumour Biol. 1999 Jul-Aug;20(4):218-24.

PMID:
10393532
12.

[Iatrogenic effect of various therapeutic and diagnostic methods on a sick child].

Mozalevskiĭ AF, Lutsenko SV.

Klin Khir. 1993;(6):41-4. Review. Russian. No abstract available.

PMID:
8271699
13.

[Secretion of recombinant human epidermal growth factor into the periplasm in Escherichia coli cells].

Batchikova NV, Al'tman IB, Lutsenko SV, Smirnov VA, Nazimov IV, Eshkind LG, Siniagina EA, Azhaev AV.

Bioorg Khim. 1992 Jun;18(6):766-76. Russian.

PMID:
1417997
14.

[Expression of a synthetic gene for human interleukin-4 in E. coli cells. Preparation of a biologically active protein].

Batchikova NV, Kulagina MA, Lutsenko SV, Smirnov VA, Kanevskiĭ VIu, Riazanova LA, Nazimov IV, Sonina NV, Siniagina EA, Azhaev AV.

Bioorg Khim. 1992 May;18(5):660-70. Russian.

PMID:
1417993
15.

[Recombinant interleukin-3 expression system in E. coli].

Lutsenko SV, Gurevich AI, Ptitsyn LR, Riazanova LA, Smirnov VA.

Bioorg Khim. 1992 Mar;18(3):391-7. Russian.

PMID:
1524590
16.

[Isolation of recombinant interleukin-3 produced by E. coli].

Lutsenko SV, Gurevich AI, Kanevskiĭ VIu, Smirnov VA, Nazimov IV, Azhikina TL, Chernov IP, Rostapshov VM, Sonina NV, Azhaev AV.

Bioorg Khim. 1991 Dec;17(12):1649-54. Russian.

PMID:
1815514
17.

[Chemical-enzymatic synthesis of the amplifier of the T7 phage gene 10 and function of its structural elements].

Gurevich AI, Skaptsova NV, Lutsenko SV, Smirnov VA, Kurkin AN, Azhaev AV.

Bioorg Khim. 1991 May;17(5):647-52. Russian.

PMID:
1768291
18.

Dialdehyde ATP derivative as an affinity modifier of the Na+,K(+)-ATPase active site.

Bernikov LR, Dzhandzhugazyan KN, Lutsenko SV, Modyanov NN.

Eur J Biochem. 1990 Dec 12;194(2):413-21.

19.

[Prenatal diagnosis of hereditary systemic bone diseases].

Grechanina EIa, Gordienko IIu, Lutsenko SV, Dratver OK.

Ortop Travmatol Protez. 1989 Jul;(7):48-52. Russian. No abstract available.

PMID:
2682434
20.

Target-residues of the active site affinity modification are different in E1 and E2 forms.

Dzhandzhugazyan KN, Lutsenko SV, Modyanov NN.

Prog Clin Biol Res. 1988;268A:181-8. No abstract available.

PMID:
2843859
21.

Affinity modification of E1-form of Na+, K+-ATPase revealed Asp-710 in the catalytic site.

Ovchinnikov YuA, Dzhandzhugazyan KN, Lutsenko SV, Mustayev AA, Modyanov NN, Dzhandzugazyan KN=Dzhadzhugazyan KN.

FEBS Lett. 1987 Jun 8;217(1):111-6. Erratum in: FEBS Lett 1987 Sep 14;221(2):433.

22.

[Complex diagnosis of breast cancer].

Shumakov AG, Nekrasov PIa, Loboda VI, Lutsenko SV, Krakhmaleva LP.

Vopr Onkol. 1984;30(2):90-3. Russian.

PMID:
6702136
23.

[Pathomorphosis of the liver after cryodestruction (experimental study)].

Tashchiev RK, Lutsenko SV.

Klin Khir. 1983 Jan;(1):23-5. Russian. No abstract available.

PMID:
6834703

Supplemental Content

Loading ...
Support Center